Weight loss medications alter how the brain and kidneys manage body fluids #Science #HealthandMedicine #weightloss #liraglutide #diabetesresearch #kidneyfunction #hormones
@purescience.news
@purescience.newsWeight loss medications alter how the brain and kidneys manage body fluids #Science #HealthandMedicine #weightloss #liraglutide #diabetesresearch #kidneyfunction #hormones
@diabetologiajnl.bsky.socialCGM to track beta cell function in preclinical T1D: a novel digital biomarker to predict disease progression #T1D #CGM #DiabetesResearch link.springer.com/article/10.1... 🔓️
@lott54.bsky.socialNew diabetes pill orforglipron achieves uniform weight loss for women of all ages
#Orforglipron #DiabetesResearch #WeightLoss #DiabetesTreatment #Type2Diabetes #WeightLossResearch #GLP1 #WomensHealth
@diabetologiajnl.bsky.socialNew study: visceral fat #endocannabinoid overproduction is driven by #InsulinResistance & tissue dysfunction, not obesity alone, in mice & humans. #Type2Diabetes #AdiposeTissue #DiabetesResearch link.springer.com/article/10.1...
@diabetologiajnl.bsky.socialBAF60A preserves beta cell identity and insulin secretion via ISL1. BAF60A loss promotes dedifferentiation, while overexpression improves beta cell function #Diabetes #BetaCells #Epigenetics #DiabetesResearch link.springer.com/article/10.1...
@purescience.newsScientists may have found why diabetic wounds refuse to heal #Science #HealthandMedicine #MedicalTechnology #diabetesresearch #woundhealing #immunotherapy #chronicwounds #tissuerepair
@diabresearch-dzd.bsky.social🔬 DZD at EASD 2026:A short photo review
Exciting research, inspiring scientific sessions, prestigious awards and many valuable conversations at the DZD booth. Thank you to everyone who visited us and helped make #EASD2026 such a special event!
📸 A short photo review
#DZD #DiabetesResearch
@aiinmeditech.bsky.socialWhat makes EASD influential among diabetes experts?
Our latest KOL study examines scientific credibility, emerging treatment evidence, clinical influence, and future opportunities.
Explore the findings:
www.sperresearch.com/Case-Studies...
@diabetologiajnl.bsky.socialSeeking new triggers for #GLP-1 secretion? Sphinganine emerged as the strongest predictor of postprandial GLP-1 responses in humans - it stimulated GLP-1 release in vitro and reduced weight gain in mice #DiabetesResearch link.springer.com/article/10.1... 🔓
@ualbertasurgery.bsky.socialHuge congrats to Siyi Zhang, summer student in the Rayat Lab, for taking home top honors at the 59th Annual Summer Students' Research Day! 👏
Siyi uncovered vital clues on how to mature & protect lab-grown islet cells for diabetes-curing transplants. 🔬
@thriveabetes.bsky.socialAre you aged 18–25 and living with Type 1 or Type 2 diabetes? 👀
You don’t need any research experience.
INTERESTED?
🌐 Click the Link: buff.ly/Vqxfeii
#Type1Diabetes #Type2Diabetes #YoungAdults #StudentLife #YoungLife #DiabeticRetinaScreening #DiabetesIreland #DiabetesResearch #PPI #Ireland
@diabetologiajnl.bsky.socialSmart insulin pen systems (SPS) paired with CGM offer dose calculation, IOB tracking & adherence support. They bridge the gap between MDI & AID #T1D #Insulin #DiabetesResearch link.springer.com/article/10.1... 🔓️
@waynestatechem.bsky.socialWayne State researchers lead $5.7 million NIH study tackling insulin resistance and type 2 diabetes. Congrats to Charlie Fehl and the entire team! #wsuchemistry #chemsky #diabetesresearch
@easdnews.bsky.social✨🇮🇹 #EASD2026 is officially open! Our President, Francesco Giorgino, delivered his Presidential Address, welcoming participants from around the world to Milan for a week of groundbreaking science & connection.
We're delighted to welcome you to an inspiring week ahead!
@diabetologiajnl.bsky.socialUnimolecular GLP-1/APJ receptor co-agonism improved glucose regulation, dyslipidaemia, hepatic biomarkers and beta cell health in high-fat-fed mice, supporting this approach as a promising next-generation metabolic therapy. #GLP1 #Obesity #DiabetesResearch link.springer.com/article/10.1... 🔓️
@easdnews.bsky.social🇮🇹 The excitement is (literally & figuratively) building here in Milan as we prepare for the EASD Annual Meeting 2026!
🚀 Exciting days ahead as everything comes together for the Annual Meeting. Stay tuned and we look forward to welcoming you in Milan! 🇮🇹
@diabetologiajnl.bsky.socialHow does hepatic PDIA5 improve glucose homeostasis? Wan et al show that PDIA5 stabilises the ER stress sensor ATF6 by preventing its SYVN1-mediated ubiquitination, thereby suppressing excessive gluconeogenesis in type 2 diabetes #DiabetesResearch #T2D link.springer.com/article/10.1... 🔓
@diabetologiajnl.bsky.socialStructured lifestyle interventions promoted increases in physical activity in those with normoglycaemia and impaired glucose tolerance but not impaired fasting glucose #DiabetesResearch #T2D link.springer.com/article/10.1... 🔓️
@keystonesymposia.bsky.socialReimagining Diabetes: convening global leaders in partnership with @endocrinesociety.bsky.social
Feb 1 to 4, 2027, Keystone, CO.
Short talk abstracts & $1500 scholarships close Oct 6.
Organized by @annakrook.bsky.social, Jennifer Green, and David Moller.
@lumanity.bsky.socialWill you be at the European Association for the Study of #Diabetes (EASD) meeting in Milan? If so, be sure to reach out and connect with who will be in attendance or email [email protected] to set up time on-site.
More information can be found at buff.ly/M1f5QAV
